ITIH4 is a predictor for coronary thrombus in coronary arteriography patients

Lei Tian1, Su Zhao2, Ruiyan Zhang1

  • 1Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.

Future Cardiology
|July 23, 2024
PubMed

Insights

Inter-alpha-trypsin inhibitor heavy chain-4 (ITIH4) may aid in diagnosing coronary artery disease (CAD). Lower ITIH4 levels in CAD patients suggest its potential as a diagnostic biomarker for CAD and predicting coronary thrombus.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Biomarker Discovery

Background:

  • Coronary artery disease (CAD) diagnosis relies on invasive procedures like coronary arteriography.
  • Novel, non-invasive biomarkers are needed to improve CAD detection and risk stratification.
  • Inter-alpha-trypsin inhibitor heavy chain-4 (ITIH4) is a protein with potential, but its role in CAD is not well-established.

Purpose of the Study:

  • To investigate the diagnostic value of plasma ITIH4 levels in patients with coronary artery disease (CAD).
  • To assess the correlation of ITIH4 with established CAD markers and clinical indicators.
  • To determine if ITIH4 can predict the presence of visible thrombus in coronary arteries.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was employed to quantify plasma ITIH4 levels.
  • Patients undergoing coronary arteriography (CAG) were recruited for the study.
  • Logistic regression analysis was used to evaluate the predictive value of ITIH4.

Main Results:

  • Plasma ITIH4 levels were significantly lower in CAD patients compared to the control group.
  • ITIH4 levels showed a negative correlation with C-reactive protein (CRP).
  • ITIH4 expression correlated significantly with D-Dimer and thrombin time, and predicted visible coronary thrombus.

Conclusions:

  • ITIH4 demonstrates potential as a novel biomarker for the diagnosis of coronary artery disease (CAD).
  • ITIH4 may serve as a valuable predictor for the presence of visible thrombus in coronary arteries.
  • Further research is warranted to validate ITIH4's clinical utility in CAD management.

Related Concept Videos

Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...